Andriy Didovyk

Andriy Didovyk is a Senior Research Scientist at Vertex Pharmaceuticals with a strong interdisciplinary background in life sciences.1 He specializes in quantitative pharmacology, mathematical modeling, synthetic and structural biology, and biochemistry.

Career

Andriy has been working at Vertex Pharmaceuticals since 2017, where he initially held the position of Research Scientist II before being promoted to Senior Research Scientist in August 2021.1 In his current role, he focuses on systems biology, pharmacology, and machine learning in early drug discovery.1

Research Focus

At Vertex, Andriy's work involves:

• Computational mechanistic modeling
• Experimental investigation of disease biology and pharmacology
• Systems biology and pharmacology (both computational and experimental)1

Academic Background

Andriy Didovyk has an extensive educational background:

• Harvard University (studied Biochemistry)
• Moscow Institute of Physics and Technology (studied Applied Mathematics and Physics)
• Taras Shevchenko National University of Kyiv (studied Radiophysics)
• Ukrainian Physics and Mathematics Lyceum (studied Physics, Mathematics, and Chemistry)

Previous Positions

Before joining Vertex Pharmaceuticals, Andriy held several academic positions:

• Postdoctoral Scholar at the University of California San Diego (2012-2017)
• Postdoctoral Fellow at Harvard University (2010-2011)1

During his postdoctoral work at UCSD, he focused on systems and synthetic biology research, particularly CRISPR/Cas9 transcriptional gene circuits, in vitro synthetic biology, and theoretical aspects of biological computation.1

Achievements

Andriy received a Certificate of Distinction in Teaching from Harvard University in 2006 for teaching Mathematics in Biology.1